| 发明名称 |
COMBINATION PHARMACEUTICAL AGENTS AS INHIBITORS OF HCV REPLICATION |
| 摘要 |
<p>The present invention relates to pharmaceutical agents administered to a subject either in combination or in series for the treatment of a flaviviridae viral infection, for example, hepatitis C virus (HCV), wherein treatment comprises administering a compound effective to inhibit the function of the HCV NS5A protein and an additional compound or combinations of compounds having anti- HCV activity.</p> |
| 申请公布号 |
CA2791630(A1) |
申请公布日期 |
2011.09.09 |
| 申请号 |
CA20102791630 |
申请日期 |
2010.08.05 |
| 申请人 |
ENANTA PHARMACEUTICALS, INC. |
发明人 |
OR, YAT SUN;OWENS, CHRISTOPHER M.;BRASHER, BRADLEY B.;QIU, YAO-LING;JIANG, LIJUAN |
| 分类号 |
A61K31/4184;A61K31/4178;A61K31/422;A61K31/437;A61K31/439;A61K31/444;A61K31/506;A61K38/21;A61P31/12 |
主分类号 |
A61K31/4184 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
